Aktis Oncology lève 84M – Series A Extension Funding
Aktis Oncology, a Cambridge, MA-based biotechnology company focused on Advancement alpha radiopharmaceuticals to treat solid cancers, raised $84M in Series A funding. La ronde a été menée par Cowen Healthcare…